Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Columbia Care Inc.
  6. News
  7. Summary
    CCHW   CA1973091079

COLUMBIA CARE INC.

(CCHW)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Columbia Care : Commences Adult Use Sales at Downtown Boston Dispensary

08/10/2021 | 07:32am EDT

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company) announces that it will commence adult use sales today at its co-located downtown Boston dispensary on Milk Street, operating as Patriot Care.

“We are proud to be one of Boston’s first downtown dispensaries to offer adult use access,” said Nicholas Vita, CEO of Columbia Care. “It’s an honor to open our doors to recreational cannabis customers and offer them the same high-quality products and services our medical patients depend upon in their health and wellness journey. We are thankful to the Cannabis Control Commission, the City of Boston and the wider cannabis community for welcoming us to the Downtown Crossing neighborhood. We look forward to welcoming everyone who walks through our doors – medical patients and adult use customers alike – and validating the support we received from so many stakeholders who made this possible.”

Patriot Care was the first medical dispensary to open its doors in the city and has served patients since 2016. The dispensary will be rebranded to Cannabist in the coming weeks, as part of Columbia Care’s ongoing conversion of its retail network to Cannabist across the country. Columbia Care operates two additional medical and adult use co-located dispensaries in Massachusetts, in Lowell and Greenfield, as well as 38,000 square feet of cultivation and manufacturing capacity. The three Massachusetts dispensaries feature several of the Company's brands, including Seed & Strain, Triple Seven, Amber, PRESS, and Plant Sugar. Forage, Columbia Care’s proprietary online cannabis discovery tool, is also now available in Lowell and Boston.

Adult use shopping in Boston is by appointment only and customers can make those appointments here: https://Cannabist.shopping. For more information on Columbia Care, please visit www.col-care.com.

About Columbia Care

Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 18 U.S. jurisdictions and the EU. Columbia Care operates 126 facilities including 95 dispensaries and 31 cultivation and manufacturing facilities, including those under development. Columbia Care is one of the original providers of medical cannabis in the U.S. and now delivers industry-leading products and services to both the medical and adult-use markets. In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils, and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, gLeaf, Classix, Plant Sugar, Press, Amber and Platinum Label CBD. For more information on Columbia Care, please visit www.col-care.com.

Caution Concerning Forward-Looking Statements

This press release contains certain statements that constitute forward-looking information within the meaning of applicable securities laws and reflect the Company’s current expectations regarding future events. The Company has made assumptions with regard to its ability to execute on brand and product initiatives, which although considered reasonable by the Company, may prove to be incorrect and are subject to known and unknown risks and uncertainties that may cause actual results, performance or achievements of the Company to be materially different from those expressed or implied by any forward-looking information. Securityholders should review the risk factors discussed under “Risk Factors” in Columbia Care’s Annual Information Form dated March 31, 2021, filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com and described from time to time in documents filed by the Company with Canadian securities regulatory authorities.


© Business Wire 2021
All news about COLUMBIA CARE INC.
10/13COLUMBIA CARE : Launches Legacy California Cannabis Brand, Classix, in Five New Markets Ac..
BU
10/13Columbia Care Inc. Launches Legacy California Cannabis Brand, Classix, in Five New Mark..
CI
10/07COLUMBIA CARE : Announces Grand Opening of Cannabist Dispensary in Missouri; First Cannabi..
BU
10/07Columbia Care Announces Opening of Cannabist Dispensary in Missouri
CI
09/30COLUMBIA CARE : to Report Third Quarter 2021 Results on Friday, November 12, 2021
BU
09/30COLUMBIA CARE : Celebrates Transition to Cannabist in Downtown Boston Co-Located Adult-Use..
BU
09/30Columbia Care Inc. Receives Approval from the Cannabis Control Commission and the Bosto..
CI
09/29COLUMBIA CARE : BIPOCANN, Virginia Minority Cannabis Coalition, Nolef Turns and Columbia C..
BU
09/29BIPOCANN, Virginia Minority Cannabis Coalition, Nolef Turns and Columbia Care Join Forc..
CI
09/29COLUMBIA CARE : Commences Cultivation Operations at 34-Acre Long Island, New York Facility..
BU
More news
Financials (USD)
Sales 2021 517 M - -
Net income 2021 -17,6 M - -
Net Debt 2021 392 M - -
P/E ratio 2021 -87,8x
Yield 2021 -
Capitalization 1 287 M 1 291 M -
EV / Sales 2021 3,25x
EV / Sales 2022 1,99x
Nbr of Employees -
Free-Float 58,9%
Chart COLUMBIA CARE INC.
Duration : Period :
Columbia Care Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 3,51 $
Average target price 11,46 $
Spread / Average Target 226%
EPS Revisions
Managers and Directors
Nicholas Keane Vita Vice Chairman & Chief Executive Officer
Michael Livingstone Chief Financial Officer, VP & Controller
Michael Abbott Executive Chairman
Rosemary Mazanet Chief Scientific Officer
David James Hart Chief Operating Officer
Sector and Competitors